Chris Hibberd is the founder of Nucleix. Nucleix has raised $143M in total funding. Latest round: Series C. Based in San Diego, CA.
Chris Hibberd is the Co-Founder and CEO of Nucleix, a liquid biopsy company founded in 2008. He leads the company's mission to revolutionize cancer treatment through earlier cancer detection via non-invasive testing. Hibberd has also served as a Board Member and worked in the Medical Device industry.
Full founder directory · Investor directory · Company funding database · Fundraising library